Healthcare Trends and Market Dynamics
We invite you to explore our firm’s perspective on the major developments shaping the world of healthcare and the industry leaders orchestrating those transformations. We share firsthand accounts from the entrepreneurs driving these advancements, showcasing their successes and challenges.
In addition to these real-world narratives, our research analysts are fully immersed in identifying the major trends and technological innovations that are driving change across the healthcare spectrum. Our detailed reports break down the complexities of these developments, aiding clients to pinpoint strategic investment opportunities.
Featured Podcasts
Listen in to conversations with industry leaders and innovators that are transforming the future of Healthcare
David Hong, MD, Steve Potts, PhD, MBA, and Vivek Subbiah, MD talk Pan-Tumor Approvals in a Post-IRA World
Melanie Whittington, Head of the Leerink Center for Pharmacoeconomics, talks with Vivek Subbiah, MD, David Hong, MD, and Steve Potts, PhD, MBA to discuss if pan-tumor approval strategies offer a path forward for broader, faster adoption across larger patient populations. Given the slow physician adoption curves typical of new therapeutics and the potential for government price negotiation as early as nine years after market entry, the experts hash out if pan-tumor approval is a potential development and commercialization pathway to ramp up clinical adoption and sales early on. They discuss the challenges, data requirements, and opportunities of this relatively new development path. Dr. Hong is the Deputy Chair of the Department of Investigational Cancer Therapeutics at MD Anderson Cancer Center. Steve Potts is the CEO and Co-Founder of a Stealth Cancer Biotech. Dr. Subbiah is the Chief of Early Phase Drug Development at the Sarah Cannon Research Institute. All bring firsthand experience – wins and battle scars – with pan-tumor approvals.
Featured Research
Explore exclusive insights from our research team that are driving investment opportunities for discerning investors
Recent Articles
Read commentary and analysis from across Leerink Partners on markets, investing, and the Healthcare sector
